Pharma C Investments Plc (SVN) Price & Analysis
SVN Stock Chart & Stats
No data to display
- Day’s Range
- N/A
- 52-Week Range
- N/A
- Previous Close
- N/A
- Volume
- N/A
- Average Volume (3M)
- N/A
- Market Cap
- GBP 794.50K
- Enterprise Value
- GBP 775.23K
- Total Cash (Recent Filing)
- N/A
- Total Debt (Recent Filing)
- N/A
- Price to Earnings (P/E)
- ―
- Beta
- -0.52
- Next Earnings
- Oct 05, 2027
- EPS Estimate
- N/A
- Next Dividend Ex-Date
- N/A
- Dividend Yield
- N/A
SVN FAQ
What is Pharma C Investments Plc’s market cap?
Pharma C Investments Plc’s market cap is £794.50K.
When is Pharma C Investments Plc’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Pharma C Investments Plc overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Pharma C Investments Plc pay dividends?
Pharma C Investments Plc does not currently pay dividends.
What is Pharma C Investments Plc’s EPS estimate?
Pharma C Investments Plc’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Pharma C Investments Plc have?
Pharma C Investments Plc has 363,100,000 shares outstanding.
Which hedge fund is a major shareholder of Pharma C Investments Plc?
Currently, no hedge funds are holding shares in GB:SVN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology